| 000 | 01284 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250515051541.0 | ||
| 264 | 0 | _c20070108 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1873-5576 | ||
| 024 | 7 |
_a10.2174/156800906779010227 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFerrajoli, A | |
| 245 | 0 | 0 |
_aThe JAK-STAT pathway: a therapeutic target in hematological malignancies. _h[electronic resource] |
| 260 |
_bCurrent cancer drug targets _cDec 2006 |
||
| 300 |
_a671-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPPAR gamma _xagonists |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSTAT Transcription Factors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aFaderl, S | |
| 700 | 1 | _aRavandi, F | |
| 700 | 1 | _aEstrov, Z | |
| 773 | 0 |
_tCurrent cancer drug targets _gvol. 6 _gno. 8 _gp. 671-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/156800906779010227 _zAvailable from publisher's website |
| 999 |
_c16736894 _d16736894 |
||